HCPCS Level II code C9364 designates a porcine-derived implant (Permacol) billed by square centimeter for use in tissue reinforcement and reconstructive surgical procedures. Nationally, use of biologic implants like Permacol affects surgical supply costs, coding specificity, and payer coverage determinations because they are billed by area and can vary substantially by procedure complexity and quantity required. Clear coding is important for accurate supply accounting and claims adjudication.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for porcine-derived biologic implants, common settings where the product is used, and the implications of billing by unit area. The publication also summarizes benchmarks for utilization and coverage themes, highlights relevant policy updates that affect implant supply coding, and outlines considerations for claims documentation and reimbursement workflows. Where input data was not provided, the text notes that specific payer policy details, associated taxonomies, and ICD-10 diagnoses are not available in the input.